Pathological findings of the thyroid tissue in a patient with euthyroid Graves’ disease

Internal Medicine

Volumn 54, Issue 22, 2015, Pages 2881-2884

  Suzuki, Nami ^a   Yoshihara, Ai ^a   Yoshimura Noh, Jaeduk ^a   Kozaki, Ai ^b   Inoue, Toshu ^b   Sugino, Kiminori ^a   Ito, Koichi ^a  

^a ITO HOSPITAL   (Japan)

^b Olympia Eye Hospital   (Japan)

Author keywords

Euthyroid Graves disease; Pathological changes in thyroid tissue; Thyroid associated ophthalmopathy

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; AUTOANTIBODY; THYROTROPIN RECEPTOR;

ADULT; ARTICLE; CASE REPORT; CLINICAL DISEASE ACTIVITY INDEX; ECHOGRAPHY; ENDOCRINE OPHTHALMOPATHY; EUTHYROID GRAVES DISEASE; EXOPHTHALMOS; EYELID RETRACTION; FEMALE; FOLLOW UP; FREE THYROXINE INDEX; GRAVES DISEASE; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; RADIOIMMUNOASSAY; THYROID FUNCTION; THYROID GLAND TISSUE; THYROIDECTOMY; CARCINOMA, PAPILLARY; IMMUNOLOGY; PATHOLOGY; PROCEDURES; THYROID FUNCTION TEST;

ADULT; AUTOANTIBODIES; CARCINOMA, PAPILLARY; FEMALE; GRAVES OPHTHALMOPATHY; HUMANS; RECEPTORS, THYROTROPIN; THYROID FUNCTION TESTS; THYROIDECTOMY;

EID: 84947066734     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.54.3346     Document Type: Article

References (18)

1. Khoo DH, Eng PH, Ho SC, et al. Graves’ ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels. Thyroid 10: 1093-1100, 2000.
2. Rundle FF, Wilson CW. Asymmetry of exophthalmos in orbital tumor and Graves’s disease. Lancet 245: 51-52, 1945.
3. Tamai H, Nakagawa T, Ohsako N, et al. Changes in thyroid functions in patients with euthyroid Graves’ disease. J Clin Endocrinol Metab 50: 108-112, 1980.
4. Yoshimura-Nor J. Clinical evaluation of thyroi stimulating antibody by yamasa TSAb kit. Horumon to Rinsho (Clinical Endocrinology) 42: 167-172, 1994 (in Japanese).
5. Kasagi K. Studies on the clinical application of TSBAB measurement using TSAb kit Yamasa. Horumon to Rinsho (Clinical Endocrinology) 46: 913-924, 1998 (in Japanese).
6. Bartley GB, Fatourechi V, Kadrmas EF, et al. Clinical features of Graves’ ophthalmopathy in an incidence cohort. Am J Ophthalmol 121: 284-290, 1996.
7. Mohaseb K, Linder M, Rootman J, et al. Development and validation of a patient symptom questionnaire to facilitate early diagnosis of thyroid-associated orbitopathy in graves’ disease. Orbit 27: 419-425, 2008.
8. Eckstein AK, Losch C, Glowacka D, et al. Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy. Br J Ophthalmol 93: 1052-1056, 2009.
9. Krassas GE, Wiersinga W. Smoking and autoimmune thyroid disease: the plot thickens. Eur J Endocrinol 154: 777-780, 2006.
10. Manji N, Carr-Smith JD, Boelaert K, et al. Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype. J Clin Endocrinol Metab 91: 4873-4880, 2006.
11. Smith TJ, Tsai CC, Shih MJ, et al. Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy. Thyroid 18: 983-988, 2008.
12. Kasagi K, Hatabu H, Tokuda Y, et al. Studies on thyrotrophin receptor antibodies in patients with euthyroid Graves’ disease. Clin Endocrinol (Oxf) 29: 357-366, 1988.
13. Kasagi K, Hidaka A, Misaki T, et al. Scintigraphic findings of the thyroid in euthyroid ophthalmic Graves’ disease. J Nucl Med 35: 811-817, 1994.
14. Kosugi S, Inoue D, Sugawa H, et al. Similarity and dissimilarity between clinical and laboratory findings, especially anti-thyrotropin receptor antibody in ophthalmic Graves’ disease without persistent hyperthyroidism and hyperthyroid Graves’ disease. Endocrinol Jpn 37: 343-354, 1990.
15. Kasagi K, Hatabu H, Tokuda Y, et al. Comparison of thyroid stimulating activities measured by cyclic AMP production, those by radioiodine uptake in FRTL-5 cells and TSH-binding inhibitory activities in patients with hyperthyroid and euthyroid Graves’ diseases. Acta Endocrinol (Copenh) 117: 365-372, 1988.
16. Solomon DH, Chopra IJ, Chopra U, Smith FJ. Identification of subgroups of euthyroid graves’s ophthalmopathy. N Engl J Med 296: 181-186, 1977.
17. Teng CS, Smith BR, Clayton B, et al. Thyroid-stimulating immunoglobulins in ophthalmic Graves’ disease. Clin Endocrinol (Oxf) 6: 207-211, 1977.
18. Sato K, Yamazaki K, Yamada E, et al. Immunoglobulins of untreated Graves’ patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles. Thyroid 9: 979-988, 1999.